News
-
Adoption of Council Regulation on Innovative Medicines Initiative
On May 6th 2014, the European Council adopted the Regulation of the Innovative Medicines Initiative (IMI2) public-private partnership, the joint undertaking between the European Union and European Federation of Pharmaceutical Industries and Associations (EFPIA) that will replace IMI.
-Read more-
-
Drive the VPH initiative: become a supporting member!
Supporting members are the true engine of our organization: they effectively drive the Institute’s policy, setting agendas and proposing specific actions. Supporting members are entitled to appoint a representative to seat in the Board of Directors, which is formally the main governing body of the Institute. Don’t miss out this opportunity!
-Read more-
-
Avicenna: second project event with Industrial Researchers - June 6th, Rome
The Avicenna project is organising an important meeting in Rome next month on the future of clinical trials.
-Read more-
-
New ecancer special issue published on personalised medicine
ecancermedicalscience has published a new Special Issue on personalised medicine. This free-to-read compilation features articles on the p-medicine project "From data sharing and integration via VPH models to personalised medicine"
-Read more-
-
New postgraduate subject on Multiscale Cancer Modelling and In Silico Medicine (MSCM & ISM)
The School of Electrical and Computer Engineering (SECE) of the National Technical University of Athens (NTUA) will be opening this new post-graduate course in October 2014.
-Read more-
-
VPH Success stories: on line questionnaire
The VPH Institute has created an on-line questionnaire to collect examples of successful VPH projects. The best ones will be used as flagship of the VPH research in the future communication activities towards European policy makers to ensure the VPH potentials are largely disseminated and supported.
-Read more-
